
Results
12
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
12 companies
Hygeia Healthcare Holdings
Market Cap: HK$7.8b
Offers oncology healthcare services in the People's Republic of China.
6078
HK$12.64
7D
2.4%
1Y
-21.2%
Jinxin Fertility Group
Market Cap: HK$6.6b
An investment holding company, provides assisted reproductive services (ARS) in China and the United States.
1951
HK$2.39
7D
2.1%
1Y
-20.1%
Jiangxi Rimag Group
Market Cap: HK$5.7b
Invests and operates medical imaging centers in China.
2522
HK$14.27
7D
-6.4%
1Y
-71.0%
YSB
Market Cap: HK$4.8b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$7.02
7D
2.3%
1Y
11.6%
Shanghai Bio-heart Biological Technology
Market Cap: HK$1.7b
Shanghai Bio-heart Biological Technology Co., Ltd.
2185
HK$6.90
7D
9.7%
1Y
345.2%
Kindstar Globalgene Technology
Market Cap: HK$1.3b
An investment holding company, provides clinical testing services in the People’s Republic of China.
9960
HK$1.26
7D
0%
1Y
8.6%
Kato (Hong Kong) Holdings
Market Cap: HK$440.0m
An investment holding company, operates as a residential care home for the elderly in Hong Kong.
2189
HK$0.44
7D
-1.1%
1Y
-15.4%
Rainmed Medical
Market Cap: HK$399.4m
Operates as a vascular interventional surgical robotics company in China and internationally.
2297
HK$0.28
7D
7.5%
1Y
79.2%
Tycoon Group Holdings
Market Cap: HK$241.4m
An investment holding company, distributes and retails a suite of health and well-being related products in Mainland China, Hong Kong, Macau, Singapore, Malaysia, and internationally.
3390
HK$0.27
7D
-1.8%
1Y
-92.3%
Sinopharm Tech Holdings
Market Cap: HK$206.0m
An investment holding company, engages in trading of medical and related products in China.
8156
HK$0.33
7D
3.2%
1Y
n/a
Universal Health International Group Holding
Market Cap: HK$202.3m
An investment holding company, distributes and retails drugs and other pharmaceutical products in the northeastern region of the People’s Republic of China.
2211
HK$1.83
7D
-2.1%
1Y
56.4%
Republic Healthcare
Market Cap: HK$62.4m
An investment holding company, operates medical clinics under the Dr.
8357
HK$0.10
7D
-26.5%
1Y
13.6%